Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance TodayUS states A to Z: marijuana, THCA, delta-8, delta-9, delta-10, HHC
State-by-state mapMost read countries: marijuana, CBD and hemp status
All countries on the globeSubstances: status in every state for each one
Compare all substancesFederal hemp redefinition: P.L. 119-103, div. B, sec. 2019
Nov 12, 2026
Applies only to cannabinoids the plant cannot naturally produce.
Dec 11, 2026
The total-THC test, the 0.4 mg per container cap and the exclusion of converted cannabinoids start.
Latest regulatory actions, updated daily
All regulatory actionsHeadlines and the first four sentences are free. Full write-ups, impact reasoning and the archive are for members.
Member · $99/mo
Every rule change, the day it is made.
The price will rise. Join now and $99 a month stays your rate for life.
Become a memberOr read free: every action opens 30 days after it is published. Sign in with email
By topic
Licensing and permitsPackaging and labelingLab testing and QARetail complianceAdvertising and marketingBanking and paymentsTaxesShipping and logisticsTravel and transportLitigationSOPsFor your role
Regulators and agenciesBrands and operatorsRetailers and smoke shopsCultivatorsProcessorsLawyers and complianceInvestorsConsumers and travelersThe Regulator Brief · newsletter
Every rule change that matters, every Monday.
Free: the Monday brief, and every action 30 days after it is published.
Members: the paid weekly, daily alerts and every write-up.
Read by regulators, operators, lawyers and founders.
Cannabis lawyers
Licensed by state. Listings are not endorsements.
By state
Software and services
Compared by fit, never ranked.
Categories
For companies and firms
Be the listing operators and regulators find.
Software and services
Verified, $49/mo: domain-verified badge, your website link, a quote.
Featured, from $399/mo: labeled Featured in your category, monthly release notes.
Lawyers and firms
Claimed, $75/yr: Claimed badge and your firm's website link.
Featured, $199/mo: labeled Featured on your profile.
Claim your companyClaim a lawyer listingPlacements, flat monthly fee
State and country page sponsorshipsExclusive slot on a legality page and its postsRegulator Brief sponsorshipPresenting sponsor or mid-issue banner, free editionMember brief sponsor slotThe paid weekly, read by members onlyFeatured directory placementLabeled Featured in a software categoryCategory sponsorshipOwn one directory category across the sitePaid guest postsLabeled Paid guest post, sponsored linksWrite and partner
Pitch a paid guest postRead guest postsBecome an affiliateSend a tip or correctionContact the teamWho reads it
Regulators at federal, state and county agencies, plus the operators, lawyers and founders they regulate.
Get the media kitSee open placementsSubstances
US states, map and A to ZCountriesFederal hemp 2026: Nov 12 and Dec 11Compound index, every stateTravelling with cannabis or hempMembers get the daily alert email and every full write-up the morning it is published. Every action is free to read 30 days later.
For your role
All news and analysisGuidesAnalysisFAQsTemplates and SOPsCourt filing recapsNews by state and countrySoftware and services: Verified $49/mo, Featured from $399/mo. Lawyers and firms: Claimed $75/yr, Featured $199/mo. Listings are not endorsements.
Regulatory journalism, not legal advice. How we report
Focus keyword: FTC hemp advertising enforcement 2025
As the hemp-derived cannabinoid market flourishes across the United States, 2025 marks a pivotal year for federal enforcement—especially by the Federal Trade Commission (FTC). Following the headline-grabbing Operation CBDeceit crackdown and with aggressive new action targeting CBD, delta-8 THC, and similar hemp cannabinoids, the FTC is redefining the compliance landscape for both established and emerging hemp businesses.
This blog delivers a deep dive into the most critical enforcement trends and rule updates for the year—including endorsement and influencer guidelines, mislabeling hazards, substantiation standards, and urgent risks for marketing to kids. Whether you run a dispensary, brand, or invest in this sector, understanding FTC hemp advertising enforcement for 2025 is more essential than ever.
After the watershed Operation CBDeceit (2020–2023) campaign, the FTC signaled it was not satisfied with one-time penalties—instead, it continues to grow its toolkit for tackling deceptive practices in the hemp space. Recent years have seen:
Health-related claims in hemp/CBD advertising remain the single highest risk for enforcement. The FTC’s standard—echoed by recent joint warning letters—requires “competent and reliable scientific evidence,” typically:
Stating or implying CBD will help with anxiety, pain, sleep disorders, cancer, or other diseases—without solid science—almost universally triggers a violation. As FTC reminded marketers here, no amount of fine print will salvage an unsubstantiated claim.
Key 2025 Takeaway for Businesses: Only promote benefits that you can back with robust, reproducible studies. General wellness claims must still be truthful and non-misleading.
Don't advertise hemp cannabinoids as “non-intoxicating” unless you can rigorously defend that statement. With delta-8, delta-10, HHC, and similar compounds, the FTC is particularly concerned about:
Failure to accurately inform consumers—especially in products that may be accessible to minors—can prompt immediate enforcement, including forced label changes and market withdrawal.
The July 2023 FTC Endorsement Guides are now fully in effect for hemp and CBD marketers. These rules explicitly address:
Key 2025 Takeaway for Businesses: Train influencer partners, monitor their content, and document your review and correction process. Do not purchase or post fake reviews.
The FTC continues to pursue so-called dark patterns: deceptive interface designs or marketing tactics that:
Recent actions—including high-profile penalties for health platforms using consumer data deceptively—demonstrate that hemp/CBD companies should avoid manipulative checkout flows, unclear privacy policies, and hidden recurring fees.
Federal and state authorities are sharply escalating enforcement against kid-appealing hemp packaging—think gummies, baked goods, or vapes designed to mimic popular children’s snacks and candy.
Key 2025 Takeaway for Businesses: Avoid any packaging, imagery, or marketing that could reasonably be mistaken for products children commonly consume. Err on the side of caution.
While there is no federal minimum age for purchase of hemp-CBD, many states require businesses to implement robust age-verification controls (often 21+ for inhalable or psychoactive products). The FTC has indicated that failing to reasonably restrict access—especially for delta-8/delta-10—could constitute an unfair or deceptive practice if minors are able to purchase online.
Recent compliance guides highlight that platforms must:
For authoritative national guidance, see industry compliance tips for age-restricted sales.
Several state attorneys general are actively pursuing claims against hemp/CBD brands that overstate health benefits, downplay risks, or fail to comply with state labeling, marketing, and packaging laws. For example, Nebraska AG settlements in 2025 addressed delta-8 misbranding and child-protective packaging in addition to classic consumer deception.
The National Advertising Division has also reviewed—and often referred to the FTC—hemp/CBD campaigns for unsupported efficacy or safety claims, even where federal agencies have not yet brought suit.
Bold product innovation means nothing if it comes at the cost of non-compliance. The new playbook for 2025 prioritizes:
2025 is shaping up as the defining year for hemp advertising standards. The FTC’s assertive regulatory approach, bolstered by the FDA, state attorneys general, and the National Advertising Division, leaves no tolerance for deceptive claims, failure to disclose material connections, or marketing practices—intentional or not—exposing young people to risk.
For cannabis businesses, robust compliance isn’t just protection—it’s a competitive advantage and a brand builder.
Leverage CannabisRegulations.ai for the latest, state-specific guidance and professional tools to help your hemp or cannabis venture stay compliant. Whether you manage dispensaries, brands, or investments, our up-to-date compliance resources are your key to thriving in the evolving regulatory landscape.